Firefighters risk their lives every day—but what happens when some dangers aren’t in the flames, but in the long-term health risks they face on the job?

In this episode, we take a closer look at cancer in the fire service, especially the increased risk of blood cancer. Joining us are Dr. Sara Jahnke, Director and Senior Scientist at the Center for Fire, Rescue & EMS Health Research; Steve Fisher, a retired firefighter and cancer survivor; and Tommy Schroeder, a Portland Fire & Rescue Lieutenant and dedicated LLS volunteer. From occupational exposures to systemic change, this conversation dives deep into the science, personal experiences, and grassroots efforts to protect those who protect us. Whether you’re in the firehouse or supporting from the outside, this is a must-listen for anyone who advocates for firefighter health and safety.

Mentioned on this episode: 

Additional LLS Support Resources: 

The post Sound the Alarm: Firefighter Health, Cancer Risk, and Moving Forward first appeared on The Bloodline with LLS.

In this episode, we’re joined by Dr. Marc Hoffmann from The University of Kansas Cancer Center, to explore chronic lymphocytic leukemia (CLL)—what it is, how it’s treated today, and where research is headed. Dr. Hoffmann shares insights on treatment goals, side effect management, and the importance of shared decision making. We also touch on emerging therapies—including CAR T-cell therapy and bispecifics—and end with a message of hope for those navigating life after a CLL diagnosis.

Mentioned on this episode: 

Additional LLS Support Resources: 

Supported by AbbVie Inc., BeOne Medicines and Genentech, A Member of the Roche Group.

The post Partnering in Care: Chronic Lymphocytic Leukemia (CLL) first appeared on The Bloodline with LLS.

The cancer experience isn’t just physical—it’s deeply emotional.

Join us for this special episode recorded onsite while filming our SHARE Project video series, exploring emotional well-being in cancer survivorship. Listen in as four blood cancer survivors share how their diagnoses impacted their mental health and what helped them cope. Key Opinion Leader, psychotherapist Julie Larson, LCSW, then joins us to discuss signs of emotional distress, the role of therapy, and how resilience and support can shape the healing journey.

Mentioned on this episode: 

Additional LLS Support Resources: 

The post LIVE! At SHARE: Emotional Wellness in Survivorship first appeared on The Bloodline with LLS.

In this episode, we speak with Mary Wells, who was diagnosed with primary myelofibrosis in 2018, a rare blood cancer that falls under the umbrella of myeloproliferative neoplasms (MPN). Mary walks us through her journey, from the side effects and emotional toll of cancer to finding the right treatment that allowed her to reclaim her life.

Mary shares the ups and downs of watch-and-wait periods, switching medications, and navigating side effects. Along the way, she advocated for her own care and partnered closely with her doctor, making shared decisions that ultimately led her to a treatment that works best for her.

Mentioned on this episode: 

Additional LLS Support Resources: 

Supported by GSK plc.

The post Choosing the Path Forward: Shared Decisions in Myelofibrosis Care first appeared on The Bloodline with LLS.

Primary Central Nervous System Lymphoma (PCNSL) is a rare form of non-Hodgkin lymphoma that affects the brain, spinal cord, or eyes. In this episode, Dr. Lakshmi Nayak of Dana-Farber Cancer Institute, helps us better understand this uncommon type of lymphoma.  From early signs and symptoms to diagnosis, treatment options, and the latest clinical trials, Dr. Nayak breaks it all down in a clear and compassionate way.

Mentioned on this episode: 

Additional LLS Support Resources: 

Supported by Ono Pharma USA, Inc.

The post Breaking Down Primary CNS Lymphoma: From Rare Diagnosis to Growing Progress first appeared on The Bloodline with LLS.

En este episodio, conocemos a Sara Grisales Jaramillo, trabajadora social, gerente de Insight y del Centro de Llamadas de CancerCare. Únase a la conversación donde Sara nos identifica las disparidades en el tratamiento de cáncer, las comunidades más afectadas y les brinda consejos a los pacientes y sus cuidadores de cómo abogar por una mejor calidad de salud. 

Mencionado en este episodio: 

Recursos adicionales de soporte de LLS: 

The post Atención Médica: Su Derecho de Abogar first appeared on The Bloodline with LLS.

Curious about CAR T-cell therapy? We went straight to the source for answers.

In this episode, the LLS Patient Education team visited The University of Miami Sylvester Cancer Center to meet with Dr. Trent Wang. He answered some of the most frequently asked questions from our patients and caregivers about this innovative cancer treatment – from who’s eligible and what to expect, to side effects, caregiver roles, and exciting future developments.

Mentioned on this episode: 

Additional LLS Support Resources: 

Supported by Bristol Myers Squibb; Johnson & Johnson & Legend Biotech; and Kite, a Gilead Company.

The post CAR T-cell Therapy: Your Questions Answered first appeared on The Bloodline with LLS.

Acute myeloid leukemia (AML) is one of the most aggressive blood cancers—but science is making real progress. In this episode, Dr. Eytan Stein of Memorial Sloan Kettering breaks down what makes AML so challenging to treat, how it’s classified, and the latest therapies changing the outlook for patients. From combination therapies and menin inhibitors to future research on CAR T-cell therapy and bispecifics, this is a hopeful, expert-led look at the future of AML treatment.

Mentioned on this episode: 

Additional LLS Support Resources: 

Supported by Abbvie Inc.; Astellas Pharma US Inc.; Genentech, A Member of the Roche Group; and Kura Oncology, Inc.

The post Understanding AML: The Challenges, The Progress, The Hope first appeared on The Bloodline with LLS.

Join us as we speak with Ashlee and Michael Cramer, the mother-son duo behind the Michael and Mom Talk Cancer podcast. Diagnosed at 19 with a rare and aggressive type of lymphoma, Michael endured intense treatments while Ashlee became his full-time caregiver. Together, they turned their pain into purpose—creating a platform to support other young adults and caregivers navigating cancer. In this episode, they open up about diagnosis, survivorship, and the unbreakable bond that grew from their shared experience. Tune in for an inspiring conversation about finding strength, hope, and beauty in life’s hardest moments.

Mentioned on this episode: 

Additional LLS Support Resources: 

The post Unbreakable: A Mother & Son’s Fight Against Cancer first appeared on The Bloodline with LLS.

When it comes to cancer and nutrition, there’s a lot of misinformation out there. Can sugar fuel cancer? Should you cut out carbs? In this episode, we’re busting some of the biggest myths about cancer nutrition and breaking down what really matters when it comes to fueling your body during treatment and beyond.

Join us as we chat with LLS Registered Dietitians, Margaret Martin and Heather Knutson, about evidence-based nutrition strategies that can help support energy levels, manage side effects, and promote overall well-being. Plus, we’ll share how you can access free, personalized nutrition support through The Leukemia & Lymphoma Society’s Nutrition Education Services Center (NESC).

Get ready to separate fact from fiction and take the guesswork out of eating well during cancer!

Mentioned on this episode: 

Free Nutrition Consultations – LLS Nutrition Education Services Center (NESC)

Additional LLS Support Resources: 

Supported by Johnson & Johnson.

The post Cancer Nutrition: Myth Busters Edition first appeared on The Bloodline with LLS.